Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5)

Mary M. McDermott; Christopher R. Martens; Kathryn J. Domanchuk; Dongxue Zhang; Clara B. Peek; Michael H. Criqui; Luigi Ferrucci; Philip Greenland; Jack M. Guralnik; Karen J. Ho; Melina R. Kibbe; Kate Kosmac; Donald Lloyd-Jones; Charlotte A. Peterson; Robert Sufit; Lu Tian; Stephanie Wohlgemuth; Lihui Zhao; Pei Zhu; Christiaan Leeuwenburgh

doi:10.1038/s41467-024-51289-7

Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5)

Mary M. McDermott, Christopher R. Martens, Kathryn J. Domanchuk, Dongxue Zhang, Clara B. Peek, Michael H. Criqui, Luigi Ferrucci, Philip Greenland, Jack M. Guralnik, Karen J. Ho, Melina R. Kibbe, Kate Kosmac, Donald Lloyd-Jones, Charlotte A. Peterson, Robert Sufit, Lu Tian, Stephanie Wohlgemuth, Lihui Zhao, Pei Zhu, Christiaan Leeuwenburgh

Research output: Contribution to journal › Comment/debate

Abstract

Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-49092-5, published online 13 June 2024 The abstract for this article was inadvertently truncated after the text ‘…A larger clinical trial to confirm these findings is needed.’; the following text was missing ‘Clinical Trials.gov registration: NCT03743636’. The original article has been updated.

Original language	English
Article number	6890
Journal	Nature Communications
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41467-024-51289-7
State	Published - Dec 2024
Externally published	Yes

Access to Document

10.1038/s41467-024-51289-7

Cite this

McDermott, M. M., Martens, C. R., Domanchuk, K. J., Zhang, D., Peek, C. B., Criqui, M. H., Ferrucci, L., Greenland, P., Guralnik, J. M., Ho, K. J., Kibbe, M. R., Kosmac, K., Lloyd-Jones, D., Peterson, C. A., Sufit, R., Tian, L., Wohlgemuth, S., Zhao, L., Zhu, P., & Leeuwenburgh, C. (2024). Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5). Nature Communications, 15(1), Article 6890. https://doi.org/10.1038/s41467-024-51289-7

@article{e6bbb748929f48a59907cea8a702c184,

title = "Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5)",

abstract = "Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-49092-5, published online 13 June 2024 The abstract for this article was inadvertently truncated after the text {\textquoteleft}…A larger clinical trial to confirm these findings is needed.{\textquoteright}; the following text was missing {\textquoteleft}Clinical Trials.gov registration: NCT03743636{\textquoteright}. The original article has been updated.",

author = "McDermott, {Mary M.} and Martens, {Christopher R.} and Domanchuk, {Kathryn J.} and Dongxue Zhang and Peek, {Clara B.} and Criqui, {Michael H.} and Luigi Ferrucci and Philip Greenland and Guralnik, {Jack M.} and Ho, {Karen J.} and Kibbe, {Melina R.} and Kate Kosmac and Donald Lloyd-Jones and Peterson, {Charlotte A.} and Robert Sufit and Lu Tian and Stephanie Wohlgemuth and Lihui Zhao and Pei Zhu and Christiaan Leeuwenburgh",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1038/s41467-024-51289-7",

language = "English",

volume = "15",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Publishing Group",

number = "1",

}

McDermott, MM, Martens, CR, Domanchuk, KJ, Zhang, D, Peek, CB, Criqui, MH, Ferrucci, L, Greenland, P, Guralnik, JM, Ho, KJ, Kibbe, MR, Kosmac, K, Lloyd-Jones, D, Peterson, CA, Sufit, R, Tian, L, Wohlgemuth, S, Zhao, L, Zhu, P & Leeuwenburgh, C 2024, 'Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5)', Nature Communications, vol. 15, no. 1, 6890. https://doi.org/10.1038/s41467-024-51289-7

Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5). / McDermott, Mary M.; Martens, Christopher R.; Domanchuk, Kathryn J. et al.
In: Nature Communications, Vol. 15, No. 1, 6890, 12.2024.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5)

AU - McDermott, Mary M.

AU - Martens, Christopher R.

AU - Domanchuk, Kathryn J.

AU - Zhang, Dongxue

AU - Peek, Clara B.

AU - Criqui, Michael H.

AU - Ferrucci, Luigi

AU - Greenland, Philip

AU - Guralnik, Jack M.

AU - Ho, Karen J.

AU - Kibbe, Melina R.

AU - Kosmac, Kate

AU - Lloyd-Jones, Donald

AU - Peterson, Charlotte A.

AU - Sufit, Robert

AU - Tian, Lu

AU - Wohlgemuth, Stephanie

AU - Zhao, Lihui

AU - Zhu, Pei

AU - Leeuwenburgh, Christiaan

PY - 2024/12

Y1 - 2024/12

N2 - Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-49092-5, published online 13 June 2024 The abstract for this article was inadvertently truncated after the text ‘…A larger clinical trial to confirm these findings is needed.’; the following text was missing ‘Clinical Trials.gov registration: NCT03743636’. The original article has been updated.

AB - Correction to: Nature Communicationshttps://doi.org/10.1038/s41467-024-49092-5, published online 13 June 2024 The abstract for this article was inadvertently truncated after the text ‘…A larger clinical trial to confirm these findings is needed.’; the following text was missing ‘Clinical Trials.gov registration: NCT03743636’. The original article has been updated.

UR - http://www.scopus.com/inward/record.url?scp=85201253940&partnerID=8YFLogxK

U2 - 10.1038/s41467-024-51289-7

DO - 10.1038/s41467-024-51289-7

M3 - Comment/debate

C2 - 39134546

AN - SCOPUS:85201253940

SN - 2041-1723

VL - 15

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 6890

ER -

Correction to: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial (Nature Communications, (2024), 15, 1, (5046), 10.1038/s41467-024-49092-5)

Abstract

Access to Document

Fingerprint

Cite this